These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12198889)
21. Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate. Harris ST Osteoporos Int; 2001 Dec; 12 Suppl 3():S11-6. PubMed ID: 11846336 [TBL] [Abstract][Full Text] [Related]
22. [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show]. Praxis (Bern 1994); 2004 Sep; 93(36):1454. PubMed ID: 15487859 [No Abstract] [Full Text] [Related]
23. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Cramer JA; Amonkar MM; Hebborn A; Altman R Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664 [TBL] [Abstract][Full Text] [Related]
24. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice]. MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400 [No Abstract] [Full Text] [Related]
26. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Goeree R; Blackhouse G; Adachi J Curr Med Res Opin; 2006 Jul; 22(7):1425-36. PubMed ID: 16834841 [TBL] [Abstract][Full Text] [Related]
27. [Men also need bone protection]. MMW Fortschr Med; 2006 Nov; 148(46):48-9. PubMed ID: 17615790 [No Abstract] [Full Text] [Related]
28. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women. Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244 [No Abstract] [Full Text] [Related]
29. Iatrogenic osteoporosis. Hamdy RC South Med J; 1999 Nov; 92(11):1131-3. PubMed ID: 10586849 [No Abstract] [Full Text] [Related]
30. A review of combination regimens for osteoporosis--prevention and treatment. Miller E; Kalin MF Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706 [TBL] [Abstract][Full Text] [Related]
34. [New guideline for the treatment of osteoporosis]. Matsumoto T Nihon Rinsho; 2004 Feb; 62 Suppl 2():387-91. PubMed ID: 15035157 [No Abstract] [Full Text] [Related]
35. Pharmacoeconomic analysis of osteoporosis treatment with risedronate. Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498 [TBL] [Abstract][Full Text] [Related]
36. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?]. MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093 [No Abstract] [Full Text] [Related]
37. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis. Miller E Int J Fertil Womens Med; 2003; 48(3):122-6; discussion 137-8. PubMed ID: 12839143 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of osteoporosis. Not only measurements count]. MMW Fortschr Med; 2002 Sep; 144(35-36):56. PubMed ID: 12380363 [No Abstract] [Full Text] [Related]
39. Results of special studies with alendronate. McClung M Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743 [TBL] [Abstract][Full Text] [Related]